Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Tashima

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Antibodies (Basel, Switzerland)|December 22, 2022
Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention EffectToshihiko Tashima
Chemical & Pharmaceutical Bulletin|April 3, 2020
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated TranscytosisToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
The structural use of carbostyril in physiologically active substancesToshihiko Tashima
Antibodies (Basel, Switzerland)|July 25, 2023
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain BarrierToshihiko Tashima
Bioorganic & Medicinal Chemistry|July 4, 2015
Intriguing possibilities and beneficial aspects of transporter-conscious drug designToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|July 23, 2018
Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosisToshihiko Tashima
Biomedicines|July 27, 2022
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody ConjugatesToshihiko Tashima
Pharmaceutics|February 26, 2022
Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated TranscytosisToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|December 14, 2016
Intelligent substance delivery into cells using cell-penetrating peptidesToshihiko Tashima
Pharmaceutics|February 26, 2025
Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane TransportToshihiko Tashima
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Antibodies (Basel, Switzerland)|December 22, 2022
Delivery of Drugs into Cancer Cells Using Antibody-Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention EffectToshihiko Tashima
Chemical & Pharmaceutical Bulletin|April 3, 2020
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated TranscytosisToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
The structural use of carbostyril in physiologically active substancesToshihiko Tashima
Antibodies (Basel, Switzerland)|July 25, 2023
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain BarrierToshihiko Tashima
Bioorganic & Medicinal Chemistry|July 4, 2015
Intriguing possibilities and beneficial aspects of transporter-conscious drug designToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|July 23, 2018
Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosisToshihiko Tashima
Biomedicines|July 27, 2022
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody ConjugatesToshihiko Tashima
Pharmaceutics|February 26, 2022
Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated TranscytosisToshihiko Tashima
Bioorganic & Medicinal Chemistry Letters|December 14, 2016
Intelligent substance delivery into cells using cell-penetrating peptidesToshihiko Tashima
Pharmaceutics|February 26, 2025
Non-Invasive Delivery of CRISPR/Cas9 Ribonucleoproteins (Cas9 RNPs) into Cells via Nanoparticles for Membrane TransportToshihiko Tashima
Pageof 3